|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Stock-based compensation expense | |||||
| Depreciation | |||||
| Accretion of discounts on marketable securities | |||||
| Non-cash lease income | |||||
| Loss on termination of lease, net | |||||
| Loss on sales and disposals of fixed assets, net | |||||
| Other, net | |||||
| Change in operating assets and liabilities: | |||||
| Prepaid expenses and other assets | |||||
| Operating lease right-of-use assets and liabilities | |||||
| Operating lease liabilities | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property and equipment | |||||
| Proceeds from sale of property and equipment | |||||
| Purchases of marketable securities | |||||
| Maturities of marketable securities | |||||
| Net cash provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from the exercise of stock options and common stock issued under the 2020 EIP | |||||
| Net cash provided by financing activities | |||||
| Impact of exchange rates on cash, cash equivalents, and restricted cash | |||||
| Net (decrease) increase in cash and cash equivalents | |||||
| Cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash - beginning of period | |||||
| Cash, cash equivalents, and restricted cash - end of period | |||||
| Supplemental disclosures of noncash investing activities | |||||
| Accrued purchases of property and equipment | |||||
Loading...